Peter Attia· MD
some people said oh well you have to use nmn a metabolite that would have a more bioavailability and better profiles and this is reasonable
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
some people said oh well you have to use nmn a metabolite that would have a more bioavailability and better profiles and this is reasonable
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
some people said oh well you have to use nmn a metabolite that would have a more bioavailability and better profiles and this is reasonable and um if someone makes a good case that we should test nmn and we could afford it